RDYDr. Reddy's Laboratories Limited

$13.19-7.2% 1Y

Price

-7.2%1Y

End-of-day closes, not the intraday tick.

A mixed picture: the questions disagree

Quality mixed, nothing alarming, growth steady, the market undecided.

RyuScore 84 of 100: see how it is built
What they do

Established in 1984, we are an integrated global pharmaceutical company committed to accelerating access to affordable and innovative medicines. Our reportable operating segments are as follows:

In the company’s own words · 20-F filed May 29, 2026 · SEC EDGAR

P/En/a
Market value$11.01B
1 year-7.2%
5 years+6.7%

Charts

As reported to the SEC, without any scoring.

For the full year FY2026, revenue was INR 335.9B (+3.2% year on year) and net income INR 42.9B.

Why these answers

Each answer with the checks it was read from. Open one for the numbers.

10/19 checks · as of Oct 23, 2026

Conflicts between checks are named, never averaged, and thin data says so.